Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Ardelyx Inc (ARDX)

Ardelyx Inc (ARDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
3 Small-Cap Stocks Set To Skyrocket

These under-the-radar companies may offer greater long-term rewards.

NVDA : 122.67 (-1.31%)
MSFT : 459.28 (+0.56%)
RXRX : 7.16 (-4.02%)
$SPX : 5,509.01 (+0.62%)
ARDX : 5.28 (-30.25%)
MGNI : 13.49 (-0.30%)
NFLX : 679.58 (+0.89%)
Ardelyx: Q1 Earnings Snapshot

Ardelyx: Q1 Earnings Snapshot

ARDX : 5.28 (-30.25%)
Ardelyx: Q4 Earnings Snapshot

Ardelyx: Q4 Earnings Snapshot

ARDX : 5.28 (-30.25%)
Why Ardelyx Stock Soared Today

Ardelyx delivered a strong quarter thanks to solid demand for its first FDA-approved product. Here's what investors need to know.

ARDX : 5.28 (-30.25%)
Ardelyx: Q3 Earnings Snapshot

Ardelyx: Q3 Earnings Snapshot

ARDX : 5.28 (-30.25%)
Why Ardelyx Stock Popped Today

Ardelyx finally received the long-awaited FDA approval for its chronic kidney disease drug.

ARDX : 5.28 (-30.25%)
Why Shares of Ardelyx Were Down Wednesday

The company's hopes for approval of a drug to treat chronic kidney disease took a hit.

NVO : 142.98 (-1.68%)
ARDX : 5.28 (-30.25%)
Markets Today: Stock Indexes Push Higher Ahead of Fed Chair Powell’s Speech

Morning Markets September E-Mini S&P 500 futures (ESU2 3) this morning are up +0.27%, and Sep Nasdaq 100 E-Mini futures (NQU2 3) are up +0.12%. Stock indexes this morning are moderately higher on mild...

ESU24 : 5,571.00 (+0.04%)
NQU24 : 20,267.50 (+0.06%)
AFRM : 29.38 (-1.51%)
HAS : 57.06 (-0.80%)
ARDX : 5.28 (-30.25%)
MRVL : 71.60 (+0.85%)
HE : 8.51 (+4.03%)
DOMO : 7.79 (+2.50%)
INTU : 656.22 (+0.84%)
JWN : 21.45 (+0.94%)
S&P Futures Tick Higher Ahead of Powell’s Jackson Hole Speech

September S&P 500 futures (ESU23) are trending up +0.26% this morning as market participants awaited Federal Reserve Chair Jerome Powell’s speech for further clues on the outlook for interest rates.

ESU23 : 4,491.72s (-0.32%)
DLTR : 107.11 (-0.13%)
AMD : 164.31 (+4.20%)
MRVL : 71.60 (+0.85%)
BA : 185.42 (-0.69%)
GES : 19.91 (+1.37%)
WOSG.LN : 410.000 (+0.39%)
AFRM : 29.38 (-1.51%)
HE : 8.51 (+4.03%)
DOMO : 7.79 (+2.50%)
ARDX : 5.28 (-30.25%)
OLPX : 1.5500 (+0.65%)
Ardelyx: Q2 Earnings Snapshot

Ardelyx: Q2 Earnings Snapshot

ARDX : 5.28 (-30.25%)

Barchart Exclusives

S&P Futures Tread Water Ahead of FOMC Meeting Minutes, U.S. Economic Data on Tap
September S&P 500 E-Mini futures (ESU24) are trending up +0.05% this morning as market participants looked ahead to the release of the Federal Reserve’s June policy meeting minutes while also gearing up for a slew of U.S. economic data to gain insights into the policy outlook. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar